You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombopoietin-receptor agonist

Showing 1 - 25 of 9,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Dec 29, 2022

    Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • (no location specified)
    Jun 5, 2023

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

    Active, not recruiting
    Has Results
    • Moderate Aplastic Anemia
    • Unilineage Bone Marrow Failure Disorders
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 2, 2021

    Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

    Completed
    Has Results
    • Anemia, Aplastic
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 30, 2020

    Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

    Not yet recruiting
    • Stem Cell Transplant Complications
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jul 17, 2022

    Immune Thrombocytopenia Trial in Switzerland (romiplostim)

    Completed
    • Immune Thrombocytopenia
    • Liestal, Basel-Land, Switzerland
    • +4 more
    May 6, 2020

    Incidence of Retained Gastric Food on Endoscopy

    Not yet recruiting
    • Gastric Content Aspiration
    • Esophagogastroduodenoscopy
    • (no location specified)
    May 16, 2023

    Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

    Recruiting
    • Glaucoma, Suspect
    • Aberration, Corneal Wavefront
    • Low dosage selective alpha-2 receptor agonists topical eyedrop
    • High dosage selective alpha-2 receptor agonists topical eyedrop
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Jan 2, 2023

    Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Prostacyclin Receptor Agonist
    • Tempe, Arizona
      Celerion
    Aug 16, 2022

    Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

    Not yet recruiting
    • Gastrointestinal Cancer
    • +2 more
    • Miami, Florida
    • +1 more
    Mar 6, 2023

    Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

    Not yet recruiting
    • Overweight and Obesity
    • 24-hour ambulatory blood pressure
    • Liberal salt diet
    • (no location specified)
    Oct 4, 2023

    Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

    Recruiting
    • Stroke
    • +3 more
    • Linyi, Shangdong, China
    • +1 more
    Jun 24, 2023

    Glucagon-like Peptide-1 Receptor Agonists According to Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Bari
    Nov 4, 2023

    Glucagon-like Peptide 1 Receptor Agonists and Mental Health

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • GLP-1 receptor agonist
    • (no location specified)
    Aug 4, 2022

    Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

    Recruiting
    • Immune Thrombocytopenia Purpura
    • Cairo, Egypt
      EL-Kasr elineiy
    May 6, 2023

    Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

    Not yet recruiting
    • Adverse Effect
    • (no location specified)
    Nov 28, 2023

    Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

    Not yet recruiting
    • Adverse Effect
    • (no location specified)
    Nov 28, 2023

    Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

    Not yet recruiting
    • Adverse Effect
    • (no location specified)
    Nov 28, 2023

    Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

    Not yet recruiting
    • Adverse Effect
    • (no location specified)
    Nov 28, 2023

    Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

    Not yet recruiting
    • Asthma
    • Semaglutide Pen Injector 2.4mg weekly
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 22, 2022

    Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

    Active, not recruiting
    • Healthy
    • Singapore, Singapore
      Lilly Centre for Clinical Pharmacology
    Nov 22, 2022